Pardaxin, a fish antimicrobial peptide, exhibits antitumor activity toward murine fibrosarcoma in Vitro and in Vivo

Marine Drugs

Volumn 10, Issue 8, 2012, Pages 1852-1872

  Wu, Shu Ping ^a   Huang, Tsui Chin ^b   Lin, Ching Chun ^b   Hui, Cho Fat ^b   Lin, Cheng Hui ^a   Chen, Jyh Yih ^b  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

Antitumor; Fibrosarcoma; Pardaxin

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CASPASE 7; CASPASE 8; CASPASE 9; CATHELICIDIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; PARDAXIN; PROTEIN BAX; PROTEIN BCL 2; STAT2 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSARCOMA; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VASCULARIZATION; TUMOR VOLUME;

MURINAE; MUS;

EID: 84865963859     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md10081852     Document Type: Article

References (51)

1. Singer, S.; Corson, J.M.; Demetri, G.D.; Healey, E.A.; Marcus, K.; Eberlein, T.J. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann. Surg. 1995, 221, 185-195.
2. Daigeler, A.; Chromik, A.M.; Haendschke, K.; Emmelmann, S.; Siepmann, M.; Hensel, K.; Schmitz, G.; Klein-Hitpass, L.; Steinau, H.U.; Lehnhardt, M.; et al. Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma. Ultrasound Med. Biol. 2010, 36, 1893-1906.
3. Edmonson, J.H.; Petersen, I.A.; Shives, T.C.; Mahoney, M.R.; Rock, M.G.; Haddock, M.G.; Sim, F.H.; Maples, W.J.; O'Connor, M.I.; Gunderson, L.L.; et al. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: Initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony- stimulating factor. Cancer 2002, 94, 786-792.
4. Daigeler, A.; Brenzel, C.; Bulut, D.; Geisler, A.; Hilgert, C.; Lehnhardt, M.; Steinau, H.U.; Flier, A.; Steinstraesser, L.; Klein-Hitpass, L.; et al. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. J. Exp. Clin. Cancer Res. 2008, 27, 82.
5. Steinau, H.U.; Buttemeyer, R.; Vogt, P.; Hussmann, J.; Hebebrand, D. Limb salvage and reconstructive procedures in soft tissue sarcomas of the extremities. Recent Results Cancer Res. 1995, 138, 31-39.
6. Daigeler, A.; Lehnhardt, M.; Khadra, A.; Hauser, J.; Steinstraesser, L.; Langer, S.; Goertz, O.; Steinau, H.U. Proximal major limb amputations-a retrospective analysis of 45 oncological cases. World J. Surg. Oncol. 2009, 7, 15.
7. Cherix, S.; Speiser, M.; Matter, M.; Raffoul, W.; Lienard, D.; Theumann, N.; Mouhsine, E.; Mirimanoff, R.O.; Leyvraz, S.; Lejeune, F.J.; et al. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: Long-term results on efficacy and limb salvage in a selected group of patients. J. Surg. Oncol. 2008, 98, 148-155.
8. Grunhagen, D.J.; de Wilt, J.H.; Graveland, W.J.; Verhoef, C.; van Geel, A.N.; Eggermont, A.M. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer 2006, 106, 1776-1784.
9. Lazarovici, P.; Primor, N.; Loew, L.M. Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red Sea Moses sole (Pardachirus marmoratus). J. Biol. Chem. 1986, 261, 16704-16713. (Pubitemid 17000860)
10. Bhunia, A.; Domadia, P.N.; Torres, J.; Hallock, K.J.; Ramamoorthy, A.; Bhattacharjya, S. NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: Mechanism of outer membrane permeabilization. J. Biol. Chem. 2010, 285, 3883-3895.
11. Vad, B.S.; Bertelsen, K.; Johansen, C.H.; Pedersen, J.M.; Skrydstrup, T.; Nielsen, N.C.; Otzen, D.E. Pardaxin permeabilizes vesicles more efficiently by pore formation than by disruption. Biophys. J. 2010, 98, 576-585.
12. Hsu, J.C.; Lin, L.C.; Tzen, J.T.; Chen, J.Y. Pardaxin-induced apoptosis enhances antitumor activity in HeLa cells. Peptides 2011, 32, 1110-1116.
13. Huang, T.C.; Lee, J.F.; Chen, J.Y. Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ROS-mediated apoptosis in HT-1080 cells. Mar. Drugs 2011, 9, 1995-2009.
14. Birnboim, H.C.; Wilkinson, D.; Sandhu, J.K.; McLean, J.R.; Ross, W. Mutatect: A mouse tumour model for detecting radiation-induced mutations in vivo. Mutat. Res. 1999, 430, 275-280. (Pubitemid 30021443)
15. Sandhu, J.K.; Privora, H.F.; Wenckebach, G.; Birnboim, H.C. Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model. Am. J. Pathol. 2000, 156, 509-518. (Pubitemid 30643806)
16. Nakamoto, T.; Yoshimura, H.; Honda, T.; Nakata, K.; Taniguchi, Y.; Yoshida, A.; Uenobe, M.; Yoshioka, N.; Yamaguchi, T.; Inagawa, H.; et al. Treatments for the activating macrophages that reduces surgical stress and postoperative mortalities from bacterial infections and tumor metastases. In Vivo 2007, 21, 357-364.
17. Pan, C.Y.; Wu, J.L.; Hui, C.F.; Lin, C.H.; Chen, J.Y. Insights into the antibacterial and immunomodulatory functions of the antimicrobial peptide, epinecidin-1, against Vibrio vulnificus infection in zebrafish. Fish Shellfish Immunol. 2011, 31, 1019-1025.
18. Pan, C.Y.; Lee, S.C.; Rajanbabu, V.; Lin, C.H.; Chen, J.Y. Insights into the antibacterial and immunomodulatory functions of tilapia hepcidin (TH)2-3 against Vibrio vulnificus infection in mice. Dev. Comp. Immunol. 2012, 36, 166-173.
19. Rajanbabu, V.; Pan, C.Y.; Lee, S.C.; Lin, W.J.; Lin, C.C.; Li, C.L.; Chen, J.Y. Tilapia hepcidin 2-3 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4D. J. Biol. Chem. 2010, 285, 30577-30586.
20. Pal, R.; Barenholz, Y.; Wagner, R.R. Transcription of vesicular stomatitis virus activated by pardaxin, a fish toxin that permeabilizes the virion membrane. J. Virol. 1981, 39, 641-645. (Pubitemid 11042732)
21. Primor, N.; Tu, A.T. Conformation of pardaxin, the toxin of the flatfish Pardachirus marmoratus. Biochim. Biophys. Acta 1980, 626, 299-306. (Pubitemid 11128522)
22. Shi, Y.L.; Edwards, C.; Lazarovici, P. Ion selectivity of the channels formed by pardaxin, an ionophore, in bilayer membranes. Nat. Toxins 1995, 3, 151-155.
23. Oren, Z.; Hong, J.; Shai, Y. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 1997, 272, 14643-14649. (Pubitemid 27251727)
24. Hallock, K.J.; Lee, D.K.; Omnaas, J.; Mosberg, H.I.; Ramamoorthy, A. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys. J. 2002, 83, 1004-1013. (Pubitemid 34803633)
25. Mader, J.S.; Hoskin, D.W. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin. Investig. Drugs 2006, 15, 933-946. (Pubitemid 44177845)
26. Kim, Y.J.; Varki, A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj. J. 1997, 14, 569-576. (Pubitemid 27353200)
27. Brugger, B.; Erben, G.; Sandhoff, R.; Wieland, F.T.; Lehmann, W.D. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 1997, 94, 2339-2344. (Pubitemid 27136876)
28. Porcelli, F.; Buck, B.; Lee, D.K.; Hallock, K.J.; Ramamoorthy, A.; Veglia, G. Structure and orientation of pardaxin determined by NMR experiments in model membranes. J. Biol. Chem. 2004, 279, 45815-45823.
29. Epand, R.F.; Ramamoorthy, A.; Epand, R.M. Membrane lipid composition and the interaction of pardaxin: The role of cholesterol. Protein Pept. Lett. 2006, 13, 1-5.
30. Ramamoorthy, A.; Lee, D.K.; Narasimhaswamy, T.; Nanga, R.P. Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR. Biochim. Biophys. Acta 2010, 1798, 223-227.
31. Davis, A.J.; Tannock, J.F. Repopulation of tumour cells between cycles of chemotherapy: A neglected factor. Lancet Oncol. 2000, 1, 86-93.
32. Corry, J.; Rischin, D. Strategies to overcome accelerated repopulation and hypoxia-what have we learned from clinical trials? Semin. Oncol. 2004, 31, 802-808. (Pubitemid 39602686)
33. Spugnini, E.P.; Renaud, S.M.; Buglioni, S.; Carocci, F.; Dragonetti, E.; Murace, R.; Cardelli, P.; Vincenzi, B.; Baldi, A.; Citro, G. Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: An approach to improve the therapeutic index of highly toxic chemotherapy drugs. J. Transl. Med. 2011, 9, 152.
34. Mir, L.M.; Devauchelle, P.; Quintin-Colonna, F.; Delisle, F.; Doliger, S.; Fradelizi, D.; Belehradek, J., Jr.; Orlowski, S. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br. J. Cancer 1997, 76, 1617-1622. (Pubitemid 27520591)
35. Spugnini, E.P.; Porrello, A. Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J. Exp. Clin. Cancer Res. 2003, 22, 571-580. (Pubitemid 38222043)
36. Spugnini, E.P.; Citro, G.; D'Avino, A.; Baldi, A. Potential role of electrochemotherapy for the treatment of soft tissue sarcoma: First insights from preclinical studies in animals. Int. J. Biochem. Cell Biol. 2008, 40, 159-163. (Pubitemid 350137883)
37. Spugnini, E.P.; Baldi, A.; Vincenzi, B.; Bongiorni, F.; Bellelli, C.; Citro, G.; Porrello, A. Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: A preliminary study in a spontaneous feline model. Cancer Chemother. Pharmacol. 2007, 59, 375-381. (Pubitemid 46025525)
38. Sitaram, N.; Nagaraj, R. Interaction of antimicrobial peptides with biological and model membranes: Structural and charge requirements for activity. Biochim. Biophys. Acta 1999, 1462, 29-54.
39. Thennarasu, S.; Nagaraj, R. Specific antimicrobial and hemolytic activities of 18-residue peptides derived from the amino terminal region of the toxin pardaxin. Protein Eng. 1996, 9, 1219-1224.
40. Lin, M.C.; Lin, S.B.; Chen, J.C.; Hui, C.F.; Chen, J.Y. Shrimp anti-lipopolysaccharide factor peptide enhances the antitumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice. Peptides 2010, 31, 1019-1025.
41. Hoskin, D.W.; Ramamoorthy, A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 2008, 1778, 357-375.
42. Thennarasu, S.; Tan, A.; Penumatchu, R.; Shelburne, C.E.; Heyl, D.L.; Ramamoorthy, A. Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. Biophys. J. 2010, 98, 248-257.
43. Ramamoorthy, A.; Thennarasu, S.; Tan, A.; Lee, D.K.; Clayberger, C.; Krensky, A.M. Cell selectivity correlates with membrane-specific interactions: A case study on the antimicrobial peptide G15 derived from granulysin. Biochim. Biophys. Acta 2006, 1758, 154-163.
44. Chai, W.S.; Zhu, X.M.; Li, S.H.; Fan, J.X.; Chen, B.Y. Role of Bcl-2 family members in caspase-3/9-dependent apoptosis during Pseudomonas aeruginosa infection in U937 cells. Apoptosis 2008, 13, 833-843.
45. Brunelle, J.K.; Letai, A. Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 2009, 122, 437-441.
46. Medan, D.; Luanpitpong, S.; Azad, N.; Wang, L.; Jiang, B.H.; Davis, M.E.; Barnett, J.B.; Guo, L.; Rojanasakul, Y. Multifunctional Role of Bcl-2 in Malignant Transformation and Tumorigenesis of Cr(VI)-Transformed Lung Cells. PLoS One 2012, 7, e37045.
47. Hsu, J.C.; Lin, L.C.; Tzen, J.T.; Chen, J.Y. Characteristics of the antitumor activities in tumor cells and modulation of the inflammatory response in RAW264.7 cells of a novel antimicrobial peptide, chrysophsin-1, from the red sea bream (Chrysophrys major). Peptides 2011, 32, 900-910.
48. Pan, C.Y.; Chen, J.Y.; Lin, T.L.; Lin, C.H. In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis. Peptides 2009, 30, 1058-1068.
49. Tomayko, M.M.; Reynolds, C.P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 1989, 24, 148-154. (Pubitemid 19163397)
50. Lee, S.C.; Pan, C.Y.; Chen, J.Y. The antimicrobial peptide, epinecidin-1, mediates secretion of cytokines in the immune response to bacterial infection in mice. Peptides 2012, 36, 100-108.
51. Peng, K.C.; Pan, C.Y.; Chou, H.N.; Chen, J.Y. Using an improved Tol2 transposon system to produce transgenic zebrafish with epinecidin-1 which enhanced resistance to bacterial infection. Fish Shellfish Immunol. 2010, 28, 905-917.